Converging on Bladder Health through Design Thinking: From an Ecology of Influence to a Focused Set of Research Questions.

bladder health design thinking lower urinary tract symptom prevention public health research question development transdisciplinary women

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
17 06 2020
Historique:
received: 23 05 2020
revised: 15 06 2020
accepted: 16 06 2020
entrez: 21 6 2020
pubmed: 21 6 2020
medline: 8 10 2020
Statut: epublish

Résumé

Lower urinary tract symptoms affect a substantial number of women in the United States (U.S.) and globally. In 2015, the Prevention of Lower Urinary tract Symptoms in women (PLUS) Research Consortium was funded to establish the scientific basis for prevention efforts by (1) understanding healthy bladder function and (2) identifying risk and protective factors for bladder health in women across the lifecourse. This transdisciplinary consortium generated a list of over 600 candidate risk and protective factors for bladder health in women and girls and refined and prioritized these into 29 focused research questions to inform a national longitudinal observational study in the U.S. This paper describes that process using design thinking, a human-centered set of principles and strategies by which innovations are developed, as a framework. Design thinking is an iterative process consisting of five stages: Empathizing with end-users of innovations, Defining core principles girding the work, Ideation of all possible solutions, and rapid-cycle Prototyping and Testing of solutions. Lessons learned are offered to inform future prevention science research endeavors that might benefit from such an approach.

Identifiants

pubmed: 32560510
pii: ijerph17124340
doi: 10.3390/ijerph17124340
pmc: PMC7345219
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK106786
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106858
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106898
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106908
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106893
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106892
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106827
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106853
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States

Références

Transl Behav Med. 2016 Mar;6(1):5-16
pubmed: 27012249
Design Health (Abingdon). 2018;2(2):236-252
pubmed: 31773070
Health Aff (Millwood). 2016 Apr;35(4):590-4
pubmed: 27044956
Neurourol Urodyn. 2020 Jun;39(5):1601-1611
pubmed: 32320497
Am J Public Health. 2010 Aug;100(8):1380-7
pubmed: 20558798
Int Urogynecol J. 2015 Sep;26(9):1347-54
pubmed: 25894903
SSM Popul Health. 2016 Dec;2:425-435
pubmed: 28111630
Healthc (Amst). 2016 Mar;4(1):11-4
pubmed: 27001093
Health Promot Pract. 2020 Jul;21(4):510-524
pubmed: 31910039
J Womens Health (Larchmt). 2018 Aug;27(8):974-981
pubmed: 29792542
Int Urogynecol J. 2020 May;31(5):961-971
pubmed: 31289874
Matern Child Health J. 2015 Dec;19(12):2552-9
pubmed: 26197732
Int Urogynecol J. 2017 Jan;28(1):105-118
pubmed: 27394129
BJU Int. 2009 Aug;104(3):352-60
pubmed: 19281467
J Womens Health (Larchmt). 2019 Jun;28(6):827-841
pubmed: 31058573
Health Educ Behav. 2012 Jun;39(3):364-72
pubmed: 22267868
Neurourol Urodyn. 2020 Apr;39(4):1185-1202
pubmed: 32119156
Prev Chronic Dis. 2018 Sep 27;15:E117
pubmed: 30264690
Annu Rev Public Health. 2011;32:307-26
pubmed: 21219155
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5
pubmed: 17049716
Prev Sci. 2013 Jun;14(3):279-89
pubmed: 22983746
Low Urin Tract Symptoms. 2020 Mar 23;:
pubmed: 32207219
Soc Sci Med. 2006 Apr;62(7):1650-71
pubmed: 16198467
J Adv Nurs. 2019 Jul 9;:
pubmed: 31287183
Maturitas. 2016 Mar;85:34-41
pubmed: 26857877
Neurourol Urodyn. 2018 Nov;37(8):2951-2964
pubmed: 30136299

Auteurs

Jessica B Lewis (J)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06520, USA.

Sonya S Brady (S)

Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN 55454, USA.

Siobhan Sutcliffe (S)

Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA.

Ariana L Smith (A)

Department of Surgery, Division of Urology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Elizabeth R Mueller (E)

Division of Female Pelvic Medicine and Reconstructive Surgery, Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, Maywood, IL 60153, USA.

Kyle Rudser (K)

Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN 55455, USA.

Alayne D Markland (A)

Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, School of Medicine, University of Alabama and the Geriatric Research, Education, and Clinical CenterBirmingham, AL 35233, USA.

Ann Stapleton (A)

Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, WA 98195, USA.

Sheila Gahagan (S)

Department of Pediatrics, University of California, San Diego, CA 92161, USA.

Shayna D Cunningham (SD)

Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT 06520, USA.
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH